NFKB1 and inflammatory bowel disease: In a mouse model of dextran sodium sulfate-induced inflammatory bowel disease (IBD), hUC-MSC-EVs alleviated IBD by inhibiting neddylation through miR-326, suppressing the activation of the NF-κB signaling pathway, and reducing the production of inflammatory factors.